News alert: Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial; immunity against new variants mixed
|
The findings showed the vaccine also provided strong immunity against the UK variant, but another interim study found limited effectiveness against the variant from South Africa. |
|
Comments
Post a Comment